Core C: Enzymology Core
核心 C:酶学核心
基本信息
- 批准号:10513682
- 负责人:
- 金额:$ 746.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-16 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Alberta provinceAlphavirusBacteriaBinding SitesBiochemicalBiochemistryBiological AssayBiophysicsCOVID-19 assayCellsCollaborationsCommunitiesComplexCoronavirusCryoelectron MicroscopyDevelopmentDistantEbola virusEnzymatic BiochemistryEnzyme InhibitionEnzyme KineticsEnzymesExhibitsFilovirusFlavivirusGenerationsGoalsHIV-1InsectaInternationalLaboratoriesLeadMammalian CellMeasurementMiniaturizationMonitorMultienzyme ComplexesMultiprotein ComplexesMutationNucleotidesPolymeraseProcessProtein FamilyRNA HelicaseRNA-Directed DNA PolymeraseRecordsResearch Project GrantsResistanceResistance developmentReverse Transcriptase InhibitorsSARS coronavirusStructureSystemTechnologyTestingTranslationsUniversitiesValidationViralVirusX-Ray Crystallographyantiviral drug developmentbiophysical techniquesdensitydrug developmentdrug discoveryhigh throughput screeninginhibitorinsightinterestlead optimizationmemberprogramsprotein expressionprotein purificationprotocol developmentscreeningsingle moleculestructural biologythree dimensional structuretoolvirology
项目摘要
ABSTRACT
The overarching goal of Core C is to support READDI-AC discovery efforts in collaboration with Discovery Core
B and MedChem Core D by validation, characterization, and optimization of compounds in enzyme assays and
structural studies, and to provide the Research Projects with detailed mechanisms of action and mechanistic
insights to mitigate potential problems with resistance conferring mutations.
Enzymology Core C includes seven internationally recognized laboratories that cover complementary expertise
at the interfaces of virology, biochemistry, biophysics and structural biology. Three specific aims that describe
the central activities of Enzymology Core C:
Aim 1: Develop assays to support hit discovery efforts by Discovery Core B.
Key activities include the expression and purification of enzymes that the Research Projects and Discovery
Core B have selected as targets. Enzymology Core C will support the development of protocols for the
expression and purification of new enzyme targets and their corresponding assays to monitor activity and
inhibition. The translation of enzyme assays into high density formats to facilitate high throughput screening by
Discovery Core B is a second responsibility.
Aim 2. Structural Biology to guide hit and lead optimization.
Enzymology Core C will focus on solving 3D structures of polymerases and RNA helicases that are currently
not available to the scientific community. Priority will also be given to solving the structures of flavivirus and
alphavirus polymerases in complex with the nucleotide and non-nucleotide analog inhibitors to provide detailed
information on the inhibitor binding sites.
Aim 3. Support the Projects in detailed mechanism of action studies for lead compounds.
Functional assays will be employed to assess the inhibitory activity against the biologically relevant enzyme
target, such as measurements of the half maximal inhibitory concentration to determine compound potency.
Promising hits and leads will also be tested against homologous enzymes within the protein family as well as
distant enzymes to assess breadth and the potential for off-target activity. Enzymology Core C will provide an
array of state-of-the-art biochemical/biophysical approaches to provide MedChem Core D and the Projects with
information on the mechanisms associated with inhibition and resistance.
抽象的
核心C的总体目标是支持与Discovery Core合作的ReadDi-AC发现工作
B和Medchem核心D通过酶测定中化合物的验证,表征和优化和优化
结构研究,并为研究项目提供详细的作用机制和机械机制
洞察力减轻抗性赋予突变的潜在问题。
酶学核心C包括七个涵盖互补专业知识的国际认可的实验室
在病毒学,生物化学,生物物理学和结构生物学的界面上。描述的三个特定目标
酶学核心C的中心活动C:
目的1:开发测定法,以支持Discovery Core B的HIT发现工作。
关键活动包括研究项目和发现的酶的表达和纯化
核心B已选择为目标。酶学核心C将支持制定协议
新酶靶标及其相应测定的表达和纯化,以监测活动和
抑制。将酶测定转换为高密度格式,以促进高吞吐量筛选
发现核心B是第二个责任。
目标2。指导命中和铅优化的结构生物学。
酶学核心C将重点求解目前是聚合酶和RNA解旋酶的3D结构
科学界无法使用。还将优先考虑解决黄体病毒的结构和
与核苷酸和非核苷酸类似物抑制剂复合物中的α病毒聚合酶可提供详细的
有关抑制剂结合位点的信息。
目标3。支持铅化合物的详细行动研究机理。
功能测定将用于评估针对生物学相关酶的抑制活性
靶标,例如测量半最大抑制浓度以确定复合效力。
有希望的命中和铅也将针对蛋白质家族中的同源酶进行测试
遥远的酶评估广度和脱靶活动的潜力。酶学核心C将提供
一系列最先进的生化/生物物理方法,以提供Medchem Core D和项目
有关与抑制和抗性相关的机制的信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG E. CAMERON其他文献
CRAIG E. CAMERON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG E. CAMERON', 18)}}的其他基金
Enteroviral 2C protein as a therapeutic target
肠道病毒2C蛋白作为治疗靶点
- 批准号:
10609524 - 财政年份:2022
- 资助金额:
$ 746.26万 - 项目类别:
Enteroviral 2C protein as a therapeutic target
肠道病毒2C蛋白作为治疗靶点
- 批准号:
10450381 - 财政年份:2022
- 资助金额:
$ 746.26万 - 项目类别:
Optimizing nucleoside analog efficacy with novel exonuclease inhibitors
使用新型核酸外切酶抑制剂优化核苷类似物的功效
- 批准号:
10514274 - 财政年份:2022
- 资助金额:
$ 746.26万 - 项目类别:
Contribution of IL-32 gene expression to viral persistence
IL-32 基因表达对病毒持久性的贡献
- 批准号:
10057016 - 财政年份:2020
- 资助金额:
$ 746.26万 - 项目类别:
Contribution of IL-32 gene expression to viral persistence
IL-32 基因表达对病毒持久性的贡献
- 批准号:
10177863 - 财政年份:2020
- 资助金额:
$ 746.26万 - 项目类别:
相似国自然基金
SOCS家族成员调控鲤科鱼类特有兼具抗病毒和抗细菌功能的TLR5免疫信号通路节点分子及其机制解析-以草鱼为例
- 批准号:32373164
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
免扩增核酸定量检测技术研究及其在发热儿童细菌与病毒性感染快速鉴别中的应用
- 批准号:22304040
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
海洋超微型蓝细菌及其病毒相互作用驱动的碳氮循环耦合机制研究
- 批准号:42376096
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
沉降过程中病毒−细菌相互作用驱动的海洋碳循环及其储碳效应
- 批准号:42376122
- 批准年份:2023
- 资助金额:52.00 万元
- 项目类别:面上项目
南海季风爆发对浮游病毒和浮游细菌多样性的影响
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
BSL3 Enhancements for RNA Virus Pandemic Preparedness
BSL3 针对 RNA 病毒大流行防范的增强
- 批准号:
10611745 - 财政年份:2022
- 资助金额:
$ 746.26万 - 项目类别:
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis
基孔肯雅病毒感染和发病机制的肠道微生物群调节
- 批准号:
10379327 - 财政年份:2021
- 资助金额:
$ 746.26万 - 项目类别:
Regulation of Antiviral Responses in Plasmacytoid Dendritic Cells to Chikungunya Virus by the Gut Microbiota
肠道微生物群调节浆细胞样树突状细胞对基孔肯雅病毒的抗病毒反应
- 批准号:
10328491 - 财政年份:2021
- 资助金额:
$ 746.26万 - 项目类别: